• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.16% Nasdaq Down0.08%

    Isis Pharmaceuticals, Inc. (ISIS)

    -NasdaqGS
    56.13 Down 1.03(1.80%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 62,583   84,861   44,063   57,076  
    Cost of Revenue -   -   -   -  
    Gross Profit 62,583   84,861   44,063   57,076  
    Operating Expenses
    Research Development64,447  67,953  61,086  59,264  
    Selling General and Administrative7,466  6,827  4,471  4,462  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (9,330) 10,081   (21,494) (6,650)
    Income from Continuing Operations
    Total Other Income/Expenses Net845  12,870  1,213  411  
    Earnings Before Interest And Taxes(8,485)22,951  (20,281)(6,239)
    Interest Expense9,021  7,307  4,998  4,961  
    Income Before Tax(17,506)15,644  (25,279)(11,200)
    Income Tax Expense(789)(15,409)1,397  881  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(16,717)22,761  (26,676)(12,081)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (16,717) 31,053   (26,676) (12,081)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (16,717) 31,053   (26,676) (12,081)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.